Babcock & Wilcox Enterprises
BW
5.46
-0.18
-3.19%
Babcock & Wilcox Enterprises
US · BW
#3381 by market cap
5.46
-0.18
-3.19%
Live - 5344 symbols - heartbeat 239s ago
· 2026-10-08 10:11
Pre-market
5.62
-0.40%
After-hours
5.70
+1.06%
Overnight
5.62
-0.35%
- Market cap
- 813.35M
- P/E (TTM)i
- -54.60
- P/Bi
- 14.18
- EPSi
- -0.48
- Div yieldi
- 0.00%
- 52W posi
- 13%
Reader sentiment
Are you bullish or bearish on BW?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is -1.82, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +1.14% YoY
Margins
- Gross margin
- 24.48%
- Operating margin
- 3.90%
- Net margin
- -8.68%
Key ratios & quality
- Enterprise valuei
- 1.05B
- Altman Z-Scorei
- -1.82
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.06B | 859.11M | 566.32M | 710.87M | 609.44M | 587.45M | 581.04M | 587.68M |
| Gross profit | -129.64M | 160.26M | 165.85M | 175.05M | 145.14M | 121.47M | 126.71M | 143.85M |
| Selling & admin expenses | 223.33M | 179.01M | 154.62M | 164.85M | 152.70M | 134.94M | 124.54M | 119.48M |
| Research & development | 3.78M | 2.86M | 4.38M | 1.60M | 2.56M | 6.46M | 5.13M | 1.46M |
| Operating profit | -356.76M | -21.62M | 6.85M | 8.61M | -10.12M | -19.93M | -2.96M | 22.91M |
| Pretax profit | -555.80M | -124.45M | -3.92M | 27.29M | -5.12M | -103.61M | -91.47M | -24.57M |
| Tax | 102.22M | 5.29M | 8.18M | -2.03M | 9.07M | 5.60M | 12.80M | 8.28M |
| Net profit | -724.86M | -129.04M | -10.30M | 31.54M | -26.58M | -197.21M | -59.92M | -36.16M |
| Basic EPS | -52 | -4 | 0 | 0 | 0 | -2 | -1 | 0 |
| Diluted EPS | -52.45 | -3.87 | -0.21 | 0.26 | -0.43 | -2.38 | -0.82 | -0.48 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 148.60M | 138.86M | 149.01M | 138.81M | 214.41M | 319.72M |
| Gross profit | 27.77M | 41.46M | 37.14M | 32.90M | 43.46M | 46.64M |
| Selling & admin expenses | 28.30M | 33.33M | 29.78M | 26.67M | 44.38M | 33.70M |
| Research & development | 348.00K | 942.00K | 303.00K | -144.00K | 803.00K | 619.00K |
| Operating profit | -885.00K | 7.18M | 7.06M | 6.37M | -1.73M | 12.32M |
| Pretax profit | -13.71M | -3.41M | -1.31M | -9.04M | -75.47M | 13.18M |
| Tax | 1.92M | 4.02M | 1.03M | 1.41M | 4.15M | -1.08M |
| Net profit | -22.01M | -58.49M | 35.09M | 9.25M | -76.95M | 14.26M |
| Basic EPS | 0 | -1 | 0 | 0 | -1 | 0 |
| Diluted EPS | -0.26 | -0.63 | 0.30 | 0.05 | -0.60 | 0.07 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 549.62M | 412.22M | 396.09M | 582.43M | 557.61M | 497.59M | 553.47M | 470.68M |
| Cash & ST investments | 43.21M | 43.77M | 57.34M | 224.87M | 76.24M | 39.86M | 23.40M | 89.46M |
| Inventory | 61.32M | 63.10M | 74.45M | 79.53M | 102.64M | 97.58M | 58.30M | 60.88M |
| Total assets | 745.50M | 626.52M | 599.08M | 913.27M | 941.69M | 775.70M | 726.99M | 662.94M |
| Total current liabilities | 711.99M | 602.49M | 270.83M | 253.38M | 371.53M | 350.22M | 406.65M | 386.69M |
| Short-term debt | 176.16M | 287.28M | 4.88M | 18.78M | 8.51M | 10.83M | 129.99M | 156.96M |
| Long-term debt | -- | -- | 347.63M | 327.91M | 348.70M | 373.31M | 348.78M | 169.84M |
| Total liabilities | 1,022,794,000.00 | 921,458,000.00 | 930,054,000.00 | 854,643,000.00 | 943,778,000.00 | 976,050,000.00 | 1,010,159,000.00 | 794,479,000.00 |
| Total equity | -277.30M | -294.94M | -330.98M | 58.62M | -2.09M | -200.35M | -283.17M | -131.54M |
| Retained earnings | -1.22B | -1.34B | -1.34B | -1.32B | -1.36B | -1.57B | -1.65B | -1.70B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 482.88M | 526.90M | 479.73M | 470.68M | 491.27M | 725.44M |
| Cash & ST investments | 21.63M | 21.71M | 24.39M | 89.46M | 106.55M | 308.63M |
| Inventory | 111.49M | 65.70M | 64.56M | 60.88M | 60.74M | 60.98M |
| Total assets | 719.71M | 703.49M | 657.88M | 662.94M | 757.85M | 999.60M |
| Total current liabilities | 511.21M | 529.29M | 400.99M | 386.69M | 494.52M | 500.30M |
| Short-term debt | 237.51M | 240.56M | 173.66M | 156.96M | 75.41M | 67.16M |
| Long-term debt | 241.05M | 235.58M | 247.91M | 169.84M | 206.10M | 215.32M |
| Total liabilities | 1,022,229,000.00 | 1,012,176,000.00 | 890,091,000.00 | 794,479,000.00 | 929,940,000.00 | 942,234,000.00 |
| Total equity | -302.52M | -308.69M | -232.21M | -131.54M | -172.10M | 57.37M |
| Retained earnings | -1.67B | -1.73B | -1.70B | -1.70B | -1.78B | -1.77B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -281.89M | -176.32M | -40.81M | -111.20M | -30.64M | -42.27M | -118.74M | -68.89M |
| Depreciation & amortization | 32.00M | 23.61M | 16.81M | 18.34M | 23.99M | 21.00M | 16.71M | 10.14M |
| Free cash flow | -287.36M | -180.12M | -49.04M | -117.88M | -43.88M | -52.07M | -129.94M | -85.66M |
| Dividends paid | -- | 0 | 0 | -9.13M | -14.86M | -11.14M | -18.57M | -14.86M |
| Stock buybacks / issuance | 438.00K | 1.28M | -283.00K | 155.90M | -2.82M | -1.41M | 7.60M | 129.74M |
| Ending cash balance | 60.28M | 56.94M | 67.42M | 226.72M | 113.46M | 71.37M | 131.06M | 201.36M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -8.48M | -25.31M | -32.11M | -2.99M | 17.79M | -17.42M |
| Depreciation & amortization | 2.48M | 2.33M | 2.95M | 2.38M | 2.50M | 2.51M |
| Free cash flow | -12.81M | -28.06M | -37.63M | -7.17M | 10.66M | -24.04M |
| Dividends paid | -3.72M | 0 | -7.43M | -3.71M | -3.72M | -3.72M |
| Stock buybacks / issuance | 5.19M | 300.00K | 26.61M | 97.65M | 34.08M | 220.76M |
| Ending cash balance | 118.62M | 110.81M | 201.09M | 201.36M | 194.83M | 382.83M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -- | -247.99 | -- | -- | -- |
| ROA %i | -70.15 | -17.78 | -1.69 | 2.89 | -4.06 | -24.68 | -9.95 | -7.34 |
| ROIC %i | -- | -- | -- | -- | -1.14 | -- | -- | -- |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -49.81 | -9.32 | 6.96 | 8.67 | 3.31 | -2.03 | -2.04 | 2.73 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Current ratioi | 0.77 | 0.68 | 1.46 | 2.30 | 1.50 | 1.42 | 1.36 | 1.22 |
| Quick ratioi | 0.60 | 0.50 | 1.04 | 1.86 | 1.05 | 0.55 | 0.48 | 0.73 |
| Debt / assetsi | 23.63 | 52.05 | 64.97 | 44.10 | 43.57 | 55.98 | 71.68 | 55.61 |
| LT debt / equityi | -- | -- | -- | 1,160.99 | -- | -- | -- | -- |
| Interest coveragei | -19.84 | -1.80 | 0.91 | 1.88 | 0.65 | -0.41 | -0.32 | 0.39 |
| Revenue CAGR (3Y) %i | -15.44 | -15.44 | -24.98 | -12.53 | -10.81 | 1.23 | -6.50 | -1.20 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -- | -- | -- |
| ROA %i | -10.55 | -21.11 | -16.88 | -7.34 | -14.34 | -3.90 |
| ROIC %i | -- | -- | -- | -- | -- | -- |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -1.23 | 0.31 | 1.26 | 2.73 | -7.74 | -5.00 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 0.94 | 1.00 | 1.20 | 1.22 | 0.99 | 1.45 |
| Quick ratioi | 0.42 | 0.36 | 0.49 | 0.73 | 0.68 | 1.16 |
| Debt / assetsi | 74.49 | 73.47 | 70.45 | 55.61 | 42.49 | 32.24 |
| LT debt / equityi | -- | -- | -- | -- | -- | 445.32 |
| Interest coveragei | -0.20 | 0.05 | 0.20 | 0.39 | -1.42 | -1.49 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Babcock & Wilcox (B&W)100.00%
Quote time 2026-10-08 10:11:34 · For reference only, not investment advice and not tailored to your situation.